Cupric Chloride Shortage Update: What Patients Need to Know in 2026

The Cupric Chloride Shortage: Where Things Stand in 2026

If you rely on total parenteral nutrition (TPN), you already know the stress of hearing that one of your essential ingredients is out of stock. Cupric Chloride Injection — the IV copper supplement used in TPN — has been caught up in the ongoing wave of sterile injectable shortages that has affected hospitals and home infusion patients across the country.

This article gives you the latest information on the Cupric Chloride shortage in 2026: whether it's still ongoing, what's causing it, how much it costs, what alternatives exist, and how to find it in stock.

Is Cupric Chloride Still in Shortage?

As of early 2026, Cupric Chloride Injection continues to experience intermittent availability issues. The shortage is not a complete nationwide stockout — some manufacturers and distributors have supply, while others do not. Availability varies by region, by distributor, and even week to week.

The American Society of Health-System Pharmacists (ASHP) tracks drug shortages in real time. Trace element injections — including individual copper, zinc, and selenium products — have appeared on ASHP's shortage list multiple times over the past decade. The situation for 2026 is similar: supply exists but is inconsistent.

Key points for 2026:

• Hospira (Pfizer) continues to manufacture Cupric Chloride Injection 0.4 mg/mL in 10 mL single-dose vials
• American Regent's Tralement (multi-trace element injection containing copper) remains available as an alternative
• Some distributors report intermittent allocation limits, meaning pharmacies may only be able to order limited quantities
• 503B compounding pharmacies have stepped in to fill gaps when commercial products are unavailable

Why Is Cupric Chloride Hard to Find?

The reasons behind the Cupric Chloride shortage haven't changed much from previous years. They include:

Limited Manufacturer Base

Very few companies make individual trace element injections for TPN. The U.S. market for Cupric Chloride is primarily served by Hospira/Pfizer. With so few suppliers, any production disruption has an outsized impact on national availability.

Sterile Manufacturing Challenges

Producing sterile injectable drugs requires specialized facilities with strict FDA oversight. Equipment maintenance, quality control investigations, raw material sourcing issues, and facility upgrades can all temporarily halt production. Sterile injectables are the most frequently shorted drug category in the U.S.

Supply Chain Fragility

The entire trace element supply chain is thin. When one product goes short (say, zinc injection), demand shifts to combination products like Tralement, which in turn puts pressure on those supplies. It's a cascading effect with no quick fix.

For a deeper look, read Why Is Cupric Chloride So Hard to Find? [Explained for 2026].

How Much Does Cupric Chloride Cost in 2026?

Cupric Chloride Injection is not a retail pharmacy product — it's supplied through hospital pharmacies, home infusion companies, and specialty distributors. That makes pricing less transparent than a typical prescription.

Here's what we know about current costs:

• Wholesale price: Approximately $558 for a tray of 25 single-dose vials (250 mL total at 0.4 mg/mL), which works out to roughly $22 per vial
• Home infusion cost: Patients receiving TPN at home typically don't pay separately for trace elements — they're included in the overall TPN supply cost, which is billed to insurance
• Out-of-pocket: If you're paying out of pocket for TPN components, the trace elements are usually a small fraction of the total cost (TPN can cost $200 to $500+ per day including all components, supplies, and nursing support)

For tips on reducing costs, see How to Save Money on Cupric Chloride in 2026.

New Options and Developments

Several developments over the past few years have improved the trace element landscape:

Tralement Availability

Tralement (American Regent) — the first FDA-approved multi-trace element injection — has become a go-to alternative when individual trace elements are unavailable. Each mL contains copper 0.3 mg, zinc 3 mg, manganese 55 mcg, and selenium 60 mcg. It's indicated for patients weighing at least 10 kg.

New ANDA Approvals

The FDA approved a new ANDA (Abbreviated New Drug Application) for Cupric Chloride Injection in 2022, potentially expanding the manufacturer base. More generic approvals mean more potential suppliers, which should help stabilize supply over time.

503B Compounding

FDA-registered 503B outsourcing facilities have increasingly filled gaps in the trace element supply chain by compounding sterile copper solutions. While not identical to commercially manufactured products, these compounded alternatives can be a lifeline during shortages.

How to Find Cupric Chloride in Stock

Here are your best options for locating Cupric Chloride right now:

1. Use Medfinder to search for real-time availability
2. Contact your home infusion provider early — at least 2-4 weeks before you need a refill
3. Ask about Tralement as a substitute (see our alternatives guide)
4. Check with 503B compounding pharmacies if commercial products are unavailable
5. Call Pfizer Medical Information at 1-800-438-1985 for manufacturer-level availability updates

For a detailed walkthrough, read How to Find Cupric Chloride in Stock Near You (Tools + Tips).

Final Thoughts

The Cupric Chloride shortage in 2026 is manageable, but it requires vigilance. Stay ahead of your supply needs, work with your healthcare team to have backup plans in place, and use tools like Medfinder to check availability before you run out.

Copper may be a trace element — meaning your body only needs a small amount — but that small amount is absolutely essential. Don't let a supply chain problem become a health problem.

If you're a provider looking for clinical guidance on managing this shortage, see our provider-focused article: Cupric Chloride Shortage: What Providers and Prescribers Need to Know in 2026.